Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy

Table 2 Summary of disease site, prescription dose, PTV volume and delivery parameters

Patient	Disease site	Prescription dose	PTV volume (cm³)
1	Skull base tumor	1.8 Gy × 30 fr.	88.8
2	Skull base tumor	1.8 Gy × 30 fr.	54.0
3	Prostate cancer	2.0 Gy × 39 fr.	87.3
4	Prostate cancer	2.0 Gy × 38 fr.	46.2
5	Prostate cancer	2.0 Gy × 38 fr.	77.8
6	Prostate cancer	2.0 Gy × 38 fr.	76.6
7	Prostate cancer	2.0 Gy × 36 fr.	75.4
8	Prostate cancer	2.0 Gy × 38 fr.	49.1
9	Prostate cancer	2.0 Gy × 36 fr.	47.2
10	Prostate cancer	2.0 Gy × 37 fr.	71.3
11	Prostate cancer	2.0 Gy × 38 fr.	61.2
12	Prostate cancer	2.0 Gy × 38 fr.	53.4
13	Prostate cancer	2.0 Gy × 39 fr.	87.3
14	Prostate cancer	2.0 Gy × 38 fr.	53.5
15	Prostate cancer	2.0 Gy × 38 fr.	64.6

ISSN: 1748-717X